Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Population-based HPV genotype attribution in HPV-associated cancers, United States
Filetype[PDF-1006.96 KB]


  • Supporting Files:
    No Additional Files
    1. 9-valent HPV (9vHPV) vaccine program key results
      Personal Author:
      Luxembourg, Alain
      Corporate Authors:
      Merck Research Laboratories.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      05-HPV-Markowitz.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 255.99 KB]
    2. HPV type attribution in high grade cervical lesions in the United States
      Personal Author:
      Hariri, Susan
      Corporate Authors:
      National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention (U.S.). Division of Sexually Transmitted Disease Prevention.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      04-Pneumo-Pilishvili.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 577.44 KB]
    3. Human papillomavirus (HPV) vaccine session
      Personal Author:
      Bocchini, Joseph A.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      04-Mening-Patel.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 188.38 KB]
    4. Summary and future ACIP HPV Vaccine Workgroup plans
      Personal Author:
      Markowitz, Lauri E.
      Corporate Authors:
      National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      06-Flu-Cano.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 277.03 KB]
You May Also Like:
  1. Cancers associated with human papillomavirus, United States—2013–2017
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
    Published Date:
    September 2020
    Series:
    United States cancer statistics data brief ; no. 18
    Description:
    Human papillomavirus (HPV) is a recognized cause of cancer. Although most HPV infections are asymptomatic and clear spontaneously, persistent infections can progress to precancer or cancer. HPV causes most cervical cancers, as well as some cancers of...
    File Type:
    Filetype[PDF - 566.46 KB]
  2. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019
    Personal Author:
    Elam-Evans, Laurie D.; Yankey, David; Singleton, James A.; Sterrett, Natalie; Markowitz, Lauri E.; Williams, Charnetta L.; Fredua, Benjamin; McNamara, Lucy; Stokley, Shannon;
    Published Date:
    August 21 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(33):1109-1116
    Description:
    Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents aged 11-12 years to protect against 1) pertussis; 2) meningococcal disease caused by types A, C, W, and Y; and 3) human p...
    File Type:
    Filetype[PDF - 201.28 KB]
  3. Coming Soon
    Primary care physician support for harmonizing HPV vaccination recommendations across genders — United States, 2018
    Personal Author:
    Meites, Elissa; Markowitz, Lauri E.; Kempe, Allison; O’Leary, Sean T.; Crane, Lori A.; Hurley, Laura P.; Brtnikova, Michaela; Beaty, Brenda L.; Stokley, Shannon; Lindley, Megan C.;
    Published Date:
    April 08 2020
    Source:
    Vaccine. 38(21):3699-3701
    Description:
    In the United States, human papillomavirus (HPV) catch-up vaccination has been nationally recommended for women and men of different ages. We surveyed national networks of primary care physicians specializing in family medicine, pediatrics, and inter...
    Public Access
    Available on:
    May 06, 2021
  4. HPV vaccination is the best protection against 6 types of cancer
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    JANUARY 2020
    Description:
    Cervical cancer is the only type of HPV cancer with a recommended screening test to detect it at an early stage.HPV is cancer prevention.For additional information, visit: www.cdc.gov/HPVLast updated JANUARY 2020 PN300538infographic-hpv-screening-508...
    File Type:
    Filetype[PDF - 911.75 KB]
  5. Human papillomavirus vaccination among adults aged 18−26, 2013−2018
    Personal Author:
    Boersma, Peter; Black, Lindsey I.;
    Corporate Authors:
    National Center for Health Statistics (U.S.). Division of Health Interview Statistics.
    Published Date:
    January 2020
    Series:
    NCHS data brief ; no. 354
    DHHS publication ; no. 2020–1209
    Description:
    Key findingsData from the National Health Interview Survey• Among adults aged 18−26, the percentage who ever received one or more doses of human papillomavirus (HPV) vaccine increased from 22.1% in 2013 to 39.9% in 2018.• The percentage of adul...
    File Type:
    Filetype[PDF - 445.92 KB]